Close Menu

This article has been updated to note that 16,500 babies in the US are identified with a rare condition through newborn screening.

NEW YORK (GenomeWeb) – The American College of Medical Genetics and Genomics (ACMG) is developing new clinical decision support tools to help doctors discuss with patients incidental findings from exome and genome sequencing, as well as results of non-invasive prenatal testing, and guide them through follow-up evaluations.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.